Cite
HARVARD Citation
Nordberg, L. et al. (2018). Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. RMD open. 4 (2), p. . [Online].